REGENXBIO logo

REGENXBIO

RGNX | NASDAQ
Chart Builder DCF Calculator
$7.32
-$0.32 (-4.19%)
At close: Nov 16, 2026, 4:00 PM ET
$7.32
$0.00 (0.00%)
After-hours: Nov 16, 2026, 7:30 PM ET
-4.19%

Rating

Updated: Nov 16, 2026
51
Fundamentals Average
Market Sentiment Neutral
Moat Narrow
Sector Rank #262/1021 (Top 26%)

Key Statistics

Market Data

Market Cap $484.02M
1D Range
7.30 7.82
52W Range
5.65 15.98

Valuation (TTM)

PE -2.28
PB 3.27
EV/EBITDA -2.31

Valuation (NTM)

Forward PE N/A
Forward PEG 0.19
Price Target $18.00
Loading financial charts...

Profile

REGENXBIO Inc. is a biotechnology company operating in the clinical stage, dedicated to developing gene therapy candidates. These therapies are designed to introduce genes into cells, aiming either to...

Sector Healthcare
Industry Biotechnology
Employees 371
IPO Date Sep 17, 2015
Fiscal Year January - December

Latest News

No news articles available yet.

Earnings

Latest Earnings
Nov 5, 2026
EPS
-$0.62
Beat +51.94%
REV
$9.16M
Miss -15.87%
Next Earnings
Mar 4, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
9
Consensus
Buy
Price Target
$18.00
Upside
+145.90%
Buy (7)
Hold (2)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.